The global production of Abacavir Sulfate Active Pharmaceutical Ingredient (API) is managed by a relatively select number of specialized manufacturers. Several firms across regions like Europe and the America hold significant portions in this critical segment of the pharmaceutical sector. Purity is of the utmost importance, necessitating stringent